At Gilead our pursuit of a healthier world for all people has yielded a cure for hepatitis C, revolutionary improvements in HIV treatment and prevention as well as advancements in therapies for viral and inflammatory diseases and certain cancers. We set and achieve bold ambitions in our fight against the world’s most devastating diseases, united in our commitment to confronting the largest public health challenges of our day and improving the lives of patients for generations to come. The Director, BIC/LEN USMA Commercialization Team Lead will play a key leadership role within the US Medical affairs (USMA) organization, reporting to the Executive Director of the HIV Treatment Strategy team. This position will focus on supporting the commercialization strategy for the BIC/LEN portfolio, ensuring medical alignment with brand objectives and cross-functional plans. The Director will collaborate closely with internal and external stakeholders to drive medical initiatives that support current HIV treatment therapies and prepare for future launches.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Director
Education Level
Ph.D. or professional degree
Number of Employees
5,001-10,000 employees